000 | 01839 a2200517 4500 | ||
---|---|---|---|
005 | 20250516020900.0 | ||
264 | 0 | _c20110331 | |
008 | 201103s 0 0 eng d | ||
022 | _a1365-2141 | ||
024 | 7 |
_a10.1111/j.1365-2141.2010.08463.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _avan Tilburg, Cornelis M | |
245 | 0 | 0 |
_aImpact of reduced chemotherapy treatment for good risk childhood acute lymphoblastic leukaemia on infectious morbidity*. _h[electronic resource] |
260 |
_bBritish journal of haematology _cFeb 2011 |
||
300 |
_a433-40 p. _bdigital |
||
500 | _aPublication Type: Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAmbulatory Care |
650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFever _xchemically induced |
650 | 0 | 4 |
_aHospitalization _xstatistics & numerical data |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNeoplasm, Residual |
650 | 0 | 4 |
_aOpportunistic Infections _xchemically induced |
650 | 0 | 4 |
_aPrecursor Cell Lymphoblastic Leukemia-Lymphoma _xcomplications |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRisk Assessment _xmethods |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSanders, Elisabeth A M | |
700 | 1 | _aNibbelke, Elisabeth E | |
700 | 1 | _aPieters, Rob | |
700 | 1 | _aRevesz, Tom | |
700 | 1 | _aWesters, Paul | |
700 | 1 | _aWolfs, Tom F W | |
700 | 1 | _aBierings, Marc B | |
773 | 0 |
_tBritish journal of haematology _gvol. 152 _gno. 4 _gp. 433-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2141.2010.08463.x _zAvailable from publisher's website |
999 |
_c20506879 _d20506879 |